FIELD: medicine, pharmaceutics.
SUBSTANCE: there are offered agent and method of treating essential tremor (ET). The drug preparation Selanc on the basis of heptapeptide of general formula Thr-Lys-Pro-Arg-Pro-Gly-Pro is offered as the agent for treating it. Using the preparation enables higher clinical effectiveness in ET ensured by correction of neuropsycological disorders and less manifested kinetic tremor.
EFFECT: improvement of dynamic praxis (patients could repeat 2-3 series of movements independently), direct and complicated choice behaviour is shown; in two weeks after the termination of treatment a long-term positive effect has been noted.
3 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
USING HEPTAPEPTIDE FOR TREATING PARKINSON'S DISEASE AND METHOD OF TREATING SUCH DISEASE | 2011 |
|
RU2450822C1 |
METHOD OF TREATING CHRONIC DERMATOSES | 2018 |
|
RU2709534C1 |
METHOD FOR TREATMENT OF PATIENTS WITH LICHEN PLANUS | 2016 |
|
RU2629601C1 |
METHOD FOR TREATMENT OF NERVOUS SYSTEM DISORDER IN CHILDREN OF YOUNGEST AGE AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2241487C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2423981C2 |
NOOTROPIC DRUG AND PHARMACEUTICAL NOOTROPIC COMPOSITION | 1994 |
|
RU2045958C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HEAD AND UPPER LIMBS TREMOR | 2016 |
|
RU2642984C1 |
USE OF METHYL ETHER OF N-CAPROYL-L-PROLYL-L-TYROSINE (DILEPT) AS AGENT WITH PSYCHOSTIMULANT ACTIVITY | 2015 |
|
RU2593886C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARKINSONIAN DISEASE AND ESSENTIAL TREMOR | 2011 |
|
RU2467697C1 |
METHOD OF TREATING NEUROSIS | 2013 |
|
RU2582971C2 |
Authors
Dates
2012-05-20—Published
2011-03-21—Filed